Schedule 13G Filing for Rezolute, Inc. by Invus Public Equities and Affiliates

On September 22, 2025, Invus Public Equities, L.P., along with its affiliates, filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Rezolute, Inc. Invus Public Equities directly held 4,171,401 shares, representing 4.6% of the outstanding shares, while Avicenna Life Sci Master Fund LP held 698,599 shares, representing 0.8%. The filing also includes entities such as Invus Public Equities Advisors, LLC, Invus Global Management, LLC, Siren, L.L.C., Avicenna Life Sci Master GP LLC, Ulys, L.L.C., and Mr. Raymond Debbane, who collectively may be deemed to beneficially own these shares. The filing certifies that the shares were not acquired for the purpose of influencing the control of Rezolute, Inc.